PAR 3.45% 28.0¢ paradigm biopharmaceuticals limited..

006 is the extension study of 002. Ideally they want long-term...

  1. 73 Posts.
    lightbulb Created with Sketch. 85
    006 is the extension study of 002. Ideally they want long-term data from at least 750 out of the 938 participants that start the 002 trial but it’s hard to know exactly how many will remain 12+ months from now. So they’ve simply assumed a 20% attrition rate for the 002 trial due to covid and other reasons for conservatism.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
-0.010(3.45%)
Mkt cap ! $97.94M
Open High Low Value Volume
29.0¢ 29.5¢ 28.0¢ $40.10K 140.9K

Buyers (Bids)

No. Vol. Price($)
5 135929 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 20969 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.